Cambrium is engineering biology to create high-performance proteins.
Cambrium's investors include Valor Equity Partners, HOF Capital, Merantix Capital, Gradient, SeaX Ventures.
Cambrium is headquartered in Berlin, Germany.
Cambrium is engineering biology to create high-performance proteins.
Cambrium is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cambrium — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/cambrium. Accessed August 14, 2026.
VCBacked. (2024). Cambrium — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cambrium
{{cite web |title=Cambrium — Funding & Investors |url=https://www.vcbacked.co/company/cambrium |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated